HOME >> BIOLOGY >> NEWS
Unusual antibiotics show promise against deadly 'superbugs'

WASHINGTON, Aug. 29 An unusual type of antibiotic being developed by chemists at University of Notre Dame shows promise in defeating deadly "superbugs" highly drug-resistant staph bacteria that are an increasing source of hospital-based infections. The novel antibiotics, which could some day save lives, were described today at the 230th national meeting of the American Chemical Society, the worlds largest scientific society.

The new antibiotics are synthetic forms of cephalosporin, a broad-spectrum antibiotic closely related to penicillin. They appear to kill bacteria by masquerading as components of the bacterial cell wall in order to deactivate an enzyme that functions as a key bacterial defense mechanism, the researchers say. In preliminary lab tests, the new antibiotics the first to exhibit this mimicry mechanism were effective against vancomycin-resistant MRSA, a rare but extremely deadly staph strain for which treatment options are extremely limited, they say.

"We are the first to demonstrate this unique strategy, which could provide a new line of defense against the growing problem of antibiotic resistance," says study leader Shahriar Mobashery, Ph.D., a chemist at the university. "As scientists, were trying to stay one step ahead of the bacteria. The more strategies there are to fight resistance, the better."

Besides fighting staph bacteria, the compounds have the potential to work against a wide range of other types of infectious bacterial strains that appear in health-care and community settings, he says. At least one of the cephalosporin compounds identified has entered Phase I clinical trials (human studies), but results are not yet available. More studies are needed before it can be marketed, Mobashery and his associates say.

MRSA (methicillin-resistant Staphylococcus aureus) was first identified in the early 1960s and has become a difficult superbug to tame. While searching for strategies to defeat it, Mobasher
'"/>


29-Aug-2005


Page: 1 2 3

Related biology news :

1. Unusual three-drug combo inhibits growth of aggressive tumors
2. Unusual data shed new light on brain and inhibiting behavior
3. Unusual mechanism keeps repair protein accurate
4. Unusual RNAs linked to chronic leukemia, may help treat it
5. Unusual reproductive behavior of odd ants surprises scientists
6. Researchers watch antibiotics, bacteria meet at atomic level
7. UBC researchers find new superbug weapon for near-empty antibiotics arsenal
8. Will the plague pathogen become resistant to antibiotics?
9. Natural antibiotics yield secrets to atom-level imaging technique
10. Compounds in cranberry juice show promise as alternatives to antibiotics
11. Protein clue to tailor-made antibiotics

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/6/2018)... ... November 06, 2018 , ... Genedata, a ... Stedim Cellca GmbH, a subsidiary of Sartorius Stedim Biotech (SSB) and a specialist ... the Genedata Bioprocess ® enterprise platform to be used at SSB laboratories ...
(Date:11/3/2018)... ... ... Karius , the leading infectious disease genomics company, is offering a ... patients. One grant of up to $50,000 will be awarded to a research institution ... addition to the funding, Karius will cover the cost of sequencing a limited number ...
(Date:11/3/2018)... Calif. (PRWEB) , ... November 01, 2018 , ... ... concerned with the morphology, physiology and pathology of the human dental pulp and ... the anatomy of the human teeth, but, over the last decade, non-destructive, high-resolution ...
Breaking Biology News(10 mins):
(Date:11/9/2018)... ... November 08, 2018 , ... uBiome, ... co-Founder, Chief Executive Officer and President of Andes Biotechnologies, to its Scientific Advisory ... Dr. Valenzuela brings to uBiome expertise on the genetic studies of hepatitis viruses. ...
(Date:11/6/2018)... ... November 06, 2018 , ... Crucial Data Solutions ... collection and management. TrialKit ™, an eClinical platform, has incorporated Apple’s biometric ... and easily sign in to the app via facial recognition or fingerprint recognition. ...
(Date:11/3/2018)... , ... November 01, 2018 , ... ... Champion Consortium Summit. Dr. Jean Mulinde, Senior Advisor, Division of Clinical Compliance Evaluation, ... monitor safety and ensure data reliability. , What should clinical research industry stakeholders ...
(Date:10/31/2018)... ... October 30, 2018 , ... The assessment of cell ... aspect of experimental biology. Reproducibility of cell-based assays is one of the key ... appropriate assay type, there are many more factors to be considered to decrease ...
Breaking Biology Technology:
Cached News: